Assessment of methodological quality of primary studies by systematic reviews: Results of the metaquality study cross sectional study

British Medical Journal

Volumn 330, Issue 7499, 2005, Pages 1053-1055

  Moja, Lorenzo P ^a   Telaro, Elena ^a   D'Amico, Roberto ^b   Moschetti, Ivan ^a   Coe, Laura ^a   Liberati, Alessandro ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COCHRANE LIBRARY; DATA ANALYSIS; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; METHODOLOGY; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; LITERATURE; STANDARD;

CROSS-SECTIONAL STUDIES; QUALITY CONTROL; RESEARCH DESIGN; REVIEW LITERATURE;

EID: 21044459830     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38414.515938.8F     Document Type: Review

References (18)

1. Juni P, Altman DG, Matthias E. Assessing the quality of randomised controlled trials. In: Egger M, Davey Smith G, Altman DG, eds. Systematic reviews in health care: meta-analysis in context, 2nd ed. London; BMJ Books, 2001.
2. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999;354:1896-900.
3. Oxman AD, Guyatt GH. Guidelines for reading literature reviews. CMAJ 1988;138:697-703.
4. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 2003;7:1-76.
5. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60.
6. Alderson P, Green S, Higgins JPT, eds. Assessment of study quality. Cochrane Reviewers' Handbook 4.2-2 [updated March 2004]; Section 6. In: The Cochrane Library, Issue 1. Chichester: Wiley, 2004. www.cochrane.org/ resources/handbook/hbook.htm (accessed 1 Apr 2005).
7. Verhagen AP, de Vet HC, de Bie RA, Boers M, van den Brandt PA. The art of quality assessment of RCTs included in systematic reviews. J Clin Epidemiol 2001;54:651-4.
8. Greenland S, O'Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics 2001;2:463-71.
9. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 1992;45:255-65.
10. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996;12:195-208.
11. Petticrew M, Song F, Wilson P, Wright K. Quality-assessed reviews of health care interventions and the database of abstracts of reviews of effectiveness (DARE). NHS CRD review, dissemination, and information teams. Int J Technol Assess Health Care 1999;15:671-8.
12. Balk EM, Bonis PA, Moskowitz H, Schmid CH, Ioannidis JP, Wang C, et al. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA 2002;287:2973-82,
13. Juni P, Egger M. Allocation concealment in clinical trials. JAMA 2002;287:2408-9,
14. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995;16:62-73.
15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
16. Tritchler D. Modelling study quality in nneta-analysis. Stat Med 1999;18;2135-45.
17. Altman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet 1990;335:149-53.
18. Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 1986;4:942-51.